LEADER 01683oam  2200433   450 
001 9910708181403321
005 20150930144642.0
035   $a(CKB)3710000000535127
035   $a(OCoLC)798496485$z(OCoLC)654519169$z(OCoLC)654619354$z(OCoLC)799664891
035   $a(EXLCZ)993710000000535127
100   $a20120708d1999      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBlood safety, minimizing plasma product risks $ehearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, September 9, 1998
210  1$aWashington :$cU.S. Government Printing Office,$d1999.
215   $a1 online resource (iii, 174 pages) $cillustrations
300   $aTitle from title screen (viewed on Sept. 30, 2015).
300   $a"Serial no. 105-189."
320   $aIncludes bibliographical references.
517   $aBlood Safety
606   $aBlood donors$xHealth and hygiene$zUnited States
606   $aBlood plasma$xSafety measures
606   $aBlood$xCollection and preservation$zUnited States$xSafety measures
608   $aLegislative hearings.$2lcgft
615  0$aBlood donors$xHealth and hygiene
615  0$aBlood plasma$xSafety measures.
615  0$aBlood$xCollection and preservation$xSafety measures.
801  0$bOCLCE
801  1$bOCLCE
801  2$bOCLCO
801  2$bOCLCQ
801  2$bGPO
906   $aBOOK
912   $a9910708181403321
996   $aBlood safety, minimizing plasma product risks$93524967
997   $aUNINA